Cure8
The VISION-AI Trial: protocol for a pragmatic randomized controlled non-inferiority trial comparing artificial intelligence-guided colonoscopy to pancolonic chromoendoscopy for neoplasia detection in adults with colorectal inflammatory bowel disease
BMC Gastroenterology

Cure8 research brief

The VISION-AI Trial: protocol for a pragmatic randomized controlled non-inferiority trial comparing artificial intelligence-guided colonoscopy to pancolonic chromoendoscopy for neoplasia detection in adults with colorectal inflammatory bowel disease

1 min read
Research and clinical trials Inflammatory bowel disease
Limited source text

What Cure8 can confirm

What We Know

Cure8 does not have enough reliable source text to summarize this article yet. Based on the article title and source metadata, this appears to be a clinical trial phase 3 related to Inflammatory bowel disease, AI and data science, Colonoscopy, and Chromoendoscopy. Use the original source link for the full details.

What Is Not Available

The source did not provide enough reliable article text for a source-grounded Cure8 brief. Study details, results, and limitations should be checked in the original source.

Source Details

Review the original publication for the complete reporting, methods, and context.

Read Original Source
Research paper Evidence type derived from source or registry metadata.
PublicationBMC Gastroenterology
PublisherSpringer Science and Business Media LLC
AuthorsLisa M.A. Laforce – van Lierop, Rebecca Dang, Neeraj Narula +3 more
Study typeJournal Article
Indexed viaCrossref
Source typeResearch paper
PublishedJul 17, 2026, 12:00 AM
Content availableMetadata only

Cure8 could not retrieve enough reliable source text to summarize this article. This page is based on the article title, source metadata, and Cure8 topic classification.

Related Reading

Browse latest news →